test

Anthony Cordone

@Armistice Capital, Llc

Latest period2024 - Q3ReportedManaged Assets$6.253BTotal holdings256
Assets growth rate-21.32%Assets growth rate (2-Q avg)-7.96%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Armistice Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 256 positions.

Assets under management

The assets under management (AUM) of Armistice Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.253B in assets, with a quarterly growth rate of -21.32% and a 2-quarter average growth rate of -7.96%. The portfolio is managed by Anthony Cordone, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
PATHUipath Inc
Recent Activity
Decreased -32.47%
0.11%
$6.28M
490,615 shares@ $12.8 avg price
ZURAZura Bio Ltd
Recent Activity
Decreased -40.57%
0.1%
$6.09M
1.5M shares@ $4.06 avg price
CRVOCervomed Inc
Recent Activity
Decreased -37.18%
0.1%
$5.869M
402,000 shares@ $14.6 avg price
ASMBAssembly Biosciences Inc
Recent Activity
Decreased -24.35%
0.09%
$5.36M
354,000 shares@ $15.14 avg price
LENLennar Corp
Recent Activity
Decreased -29.42%
0.07%
$3.756M
20,035 shares@ $187.49 avg price
CTXRCitius Pharmaceuticals Inc
Recent Activity
Decreased -28.35%
0.06%
$3.642M
7.276M shares@ $0.51 avg price
SCLXScilex Holding Co
Recent Activity
Decreased -70.62%
0.06%
$3.245M
3.51M shares@ $0.93 avg price
WWayfair Inc
Recent Activity
Decreased -40.86%
0.05%
$3.09M
55,000 shares@ $56.18 avg price
TTOOT2 Biosystems Inc
Recent Activity
Decreased -15.8%
0.05%
$2.75M
1.396M shares@ $1.97 avg price
FGENFibrogen Inc
Recent Activity
Decreased -31.56%
0.05%
$2.716M
6.8M shares@ $0.4 avg price